People on the move in this week's column include executives from LabCorp, Quintiles and PDI, plus the creative agencies working with Roche and Novartis.
LabCorp, the US genomic testing firm, has replaced CFO Brad Hayes with Glenn Eisenberg. Hayes will retire on June 16.
Eisenberg joins LabCorp from Timken, where he was CFO and Executive VP, Finance and Administration. Previously he held senior management roles at United Dominion Industries (now part of SPX Corporation).
Michael Cherney, MD of ISI Group, told Outsourcing-Pharma.com his company’s analysts viewed the hire of someone from the Industrials field “as highlighting LH [LabCorp]'s focus on execution and optimizing operations as LH continues to drive success through its five pillar strategy.
“We would expect the near-term strategic focuses to remain in place, with LH's previously announced restructuring planning likely to be at least influenced by Eisenberg's views given his historical margin focus while at TKR [Timken].”
LabCorp recently bought an “underperforming” genomics laboratory from Covance.
Copyright - Unless otherwise stated all contents of this web site are © 2014 - William Reed Business Media SAS - All Rights Reserved - Full details for the use of materials on this site can be found in the Terms & Conditions
Recipharm, Catalent, INC and PRA completed eye-catching IPOs in 2014. Which firms are likely follow suit in 2015?
Catering for low value, high volume customers as well as the growing number of firms developing complex...
Clinverse, Intertek and inVentiv are among the pharma services companies announcing new staff this week.